| 11542270 |
BCKDK inhibitors |
Leanne Marie Buzon, Kevin James Filipski, David A. Griffith, Bethany Lyn Kormos, Luis Angel Martinez-Alsina +4 more |
2023-01-03 |
$607,007,000 |
| 11203594 |
Anti-proliferative agents for treating PAH |
Douglas C. Behenna, Kimberly O. Cameron, Ping Chen, John M. Curto, Kevin Daniel Freeman-Cook +10 more |
2021-12-21 |
$2,121,061,000 |
| 11059833 |
BCKDK inhibitors |
Leanne Marie Buzon, Kevin James Filipski, David A. Griffith, Bethany Lyn Kormos, Luis Angel Martinez-Alsina +4 more |
2021-07-13 |
$442,539,000 |
| 10450297 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Kevin Daniel Freeman-Cook, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2019-10-22 |
$864,920,000 |
| 9394285 |
Indole and indazole compounds that activate AMPK |
Kimberly O. Cameron, Matthew S. Dowling, David Christopher Ebner, David James Edmonds, Dilinie Fernando +5 more |
2016-07-19 |
$914,444,000 |
| 8889730 |
Indole and indazole compounds that activate AMPK |
Kimberly O. Cameron, Matthew S. Dowling, Dilinie Fernando, David Christopher Ebner, Kevin James Filipski +4 more |
2014-11-18 |
$598,283,000 |
| 8609680 |
2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives |
Kimberly O. Cameron, Dilinie Fernando, Kim F. McClure, Daniel Wei-Shung Kung, Allyn T. Londregan +1 more |
2013-12-17 |
$649,980,000 |
| 8440822 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Kevin Daniel Freeman-Cook, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2013-05-14 |
|
| 8247411 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Kevin Daniel Freeman-Cook, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2012-08-21 |
$625,854,000 |
| 7928109 |
Sulfonyl amide derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Kevin Daniel Freeman-Cook, Matthew Merrill Hayward, Catherine Angela Hulford, Christopher Lowell Autry +3 more |
2011-04-19 |
$184,395,000 |
| 7820648 |
Pyrimidine derivatives for the treatment of abnormal cell growth |
Michael Joseph Luzzio, Donn Wishka, Gonghua Pan, Arthur Douglas Brosius, Joel Arcari +3 more |
2010-10-26 |
$292,723,000 |
| 7585869 |
Substituted heterocylces for the treatment of abnormal cell growth |
Jinshan Chen, Richard Connell, John Charles Kath, Goss S. Kauffman, Blaise S. Lippa +1 more |
2009-09-08 |
$819,438,000 |
| 7332493 |
Substituted bicyclic derivatives for the treatment of abnormal cell growth |
John Charles Kath, Joel Morris |
2008-02-19 |
$17,718,000 |
| 6927220 |
Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
Joel Morris, John Charles Kath |
2005-08-09 |
$209,850,000 |
| 6890924 |
Substituted bicyclic derivatives for the treatment of abnormal cell growth |
John Charles Kath, Joel Morris |
2005-05-10 |
$387,714,000 |
| 6867201 |
Heteroaromatic bicyclic derivatives useful as anticancer agents |
John Charles Kath, Norma Tom, Eric Cox |
2005-03-15 |
$262,568,000 |
| 6541481 |
Substituted bicyclic derivatives useful as anticancer agents |
John Charles Kath, Norma Tom, Zhengyu Liu, Eric Cox, Joel Morris |
2003-04-01 |
$432,043,000 |
| 6465449 |
Heteroaromatic bicyclic derivatives useful as anticancer agents |
John Charles Kath, Norma Tom, Eric Cox |
2002-10-15 |
$179,452,000 |
| 6284764 |
Substituted bicyclic derivatives useful as anticancer agents |
John Charles Kath, Norma Tom, Zhengyu Liu, Eric Cox, Joel Morris |
2001-09-04 |
$482,973,000 |
| 6172205 |
Synthetic process toward total synthesis of eleutherobin and its analogues and uses thereof |
Samuel J. Danishefsky, Xiao-Tao Chen, Clare E. Gutteridge, Bishan Zhou |
2001-01-09 |
|
